Inflammation-reducing drug shows no benefit for dry age-related macular degeneration in NIH trial

Description

Dry AMD affects part of the eye’s retina that allows for clear central vision.

Safety first for new GA treatment

Inflammation-reducing drug shows no benefit for dry age-related macular degeneration in NIH trial

Media Resources Clinical Center Home Page

Age-Related Macular Degeneration - Fighting Blindness Canada (FBC)

Geographic atrophy is taking center stage

Eye Health and Diet

NEI Research News National Eye Institute

Macular degeneration - age-related Information

IJMS, Free Full-Text

$ 11.00USD
Score 4.5(607)
In stock
Continue to book